from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0495c/-

LFCtreatmentdescriptionclass of inhibitor

-1.159

Amikacinug/mL Amikacintranslation

-1.468

Cap5-10ug/mL Capreomycintranslation

-2.944

Rox10-50 ug/mL Roxithromycintranslation

-0.524

SM2-5 ug/mL Streptomycintranslation

-2.240

Tet5-10 ug/mL Tetracyclinetranslation

-0.332

Rif0.2-5ug/mL Rifampicintranscription

-0.523

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.168

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.671

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.233

CPZ10-50 ug/mL Chlorpromazinerespiration

0.915

Clofazimine10-13 ug/mL Clofaziminerespiration

0.582

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.635

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.672

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

1.009

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.786

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.634

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.299

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

2.125

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.556

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

1.872

KCN5-20 ug/mL Potassium cyaniderespiration

1.024

NaN30.2-2 mM Sodium aziderespiration

-0.836

Nigericin50 uM Nigericinrespiration

0.350

TRC10-150 ug/mL Triclosanrespiration

0.264

TRZ10-25 ug/mL Thioridazinerespiration

-1.467

Valinomycin0.5-10 uM Valinomycinrespiration

-0.394

ZnSO42 mM ZnSO4respiration

0.328

menadione6-10 ug/mL Menadionerespiration

0.013

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.132

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.172

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.716

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.105

NRP_1Non-replicating persistence stage 1dosRassociated

-0.934

Amp0.2mg/mL AmpicillincellWall

-0.135

Cephalexin20-100 ug/mL CephalexincellWall

-0.061

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.773

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.865

EMB10-20 ug/mL EthambutolcellWall

-0.531

Eta12-40 ug/mL EthionamidecellWall

-0.521

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.522

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.083

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.199

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.458

BZA0.12 mg/mL BenzamidearomaticAmides

0.159

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.245

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.252

H2O24 mM hydrogen peroxideDNAdamaging

-0.657

Levo10 ug/mL LevofloxacinDNAdamaging

0.267

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.087

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.332

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.420

UVUV-irradiationDNAdamaging

-0.174

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.240

Antimycin12.5-50 ug/mL Antimycin A?

-0.218

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

1.048

PA_110-50 ug/mL Antitubercular compound PA-1?

0.576

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.972

PA8240.2-2 ug/mL PA-824?

1.847

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.480

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.359

Verapamil50 uM Verapamil?

-0.236

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.415

methoxatin10-20 ug/mL Methoxatin?